Paclitaxel Injection (protein-bound particles)

Presentation

Abraxane® 100 mg, single dose vial (NDC 68817-134-50)

Availability and Estimated Shortage Duration

Temporarily on allocation through beginning of April 2022.

Related Information

Manufacturing delay

Shortage Reason (per FDASIA)

Other

US FDA Link: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Paclitaxel%20Injection%20(protein-bound%20particles)&st=c&tab=tabs-1